OncoTrack: A new International consortium launches project in the area of genomic cancer diagnostics
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
GlaxoSmithKline and Human Genome Sciences announce FDA approval of Benlysta® (belimumab)
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
FDA accepts new drug application for investigational compound Dapagliflozin
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
Pfizer Announces Primary Endpoints Met in Second Phase 3 Clinical Trial of Tofacitinib
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Bayer extends support to fight Chagas disease
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Breakaway From Cancer(R) Launches Newly-Enhanced Website
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
More Pharma News ...
- Breaking the Taboo Associated with Hemorrhoidal Disease
- Nycomed well positioned in emerging markets
- Roche Annual General Meeting: dividend raised by 10%
- Nycomed's novel COPD therapy roflumilast receives FDA approval
- Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program
- Results Published in The Lancet Demonstrate Superiority of XGEVA(TM) (Denosumab)
- Bayer and Onyx Initiate Phase III Trial of Nexavar® in Combination with Chemotherapy